To characterize the mechanism of enhanced killing efficiency, we evaluated changes in the expression of CD19 antigen, anti-apoptotic and pro-apoptotic Bcl-2 family proteins in BH3 mimetics-pretreated tumor cells. This evidence concerns the gene BCL2 and neoplasm.